Edition:
United Kingdom

Ronin Trading, SW Investment Management nominate James Egan to Peregrine Pharmaceuticals Board


Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Ronin Trading, LLC and SW Investment Management LLC::Ronin Trading and SW Investment Management announce additional nomination to Board of Peregrine Pharmaceuticals.Ronin Trading and SW Investment Management - ‍nomination of James (Jamie) J. Egan, for election to Peregrine's Board at co's 2017 annual meeting.‍Ronin Trading and SW Investment Management say collectively have beneficial ownership of about 8.9% of Peregrine's outstanding shares of common stock​. 

Company Quote

4.33
0.02 +0.46%
18 Apr 2019